IP News from IPWatchdog: Barks & Bites for Friday, March 21Johnson & Johnson invests $55B in U.S. factories to counter drug tariffs.Federal Circuit clarifies prosecution disclaimer doctrine and trademark litigation boundaries.
Last Week's 3 Biotech IPOs Prompt Huge Insider BuyingInsider buying activity has surged following recent biopharma IPOs, indicating strong market confidence among executives.